Where Will iCAD Inc (ICAD) Stock Go Next After It Is Lower By 18.06% in a Week?

The market has been down on iCAD Inc (ICAD) stock recently. ICAD gets a Bearish score from InvestorsObserver Stock Sentiment Indicator.

iCAD Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on ICAD!

See Full ICAD Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With ICAD Stock Today?

iCAD Inc (ICAD) stock is trading at $2.95 as of 1:46 PM on Friday, Apr 22, a drop of -$0.10, or -3.28% from the previous closing price of $3.05. The stock has traded between $2.91 and $3.10 so far today. Volume today is 142,154 compared to average volume of 172,180. To screen for more stocks like iCAD Inc click here.

More About iCAD Inc

icad Inc provides cancer detection, radiation therapy and workflow solutions, primarily computer-aided detection and workflow solutions for breast, prostate and colorectal cancers. Its products include powerlook tomo detection, powerlook density assessment, and vera look. The firm has also developed a technology namely Xoft Axxent electronic brachytherapy system used in the treatment of non-melanoma skin cancer, early-stage breast cancer, and gynecological cancers. Click Here to get the full Stock Report for iCAD Inc stock.